Skip to main content

Table 3 Outcome measures by time point (Mean (SD))

From: Randomized sham controlled trial of cranial microcurrent stimulation for symptoms of depression, anxiety, pain, fatigue and sleep disturbances in women receiving chemotherapy for early-stage breast cancer

Measure

Group

Time point 1

Time point 2

Time point 3

Anxiety

Total

7.34 (4.11)

4.69 (3.46)

4.29 (3.78)

CES

7.09 (4.09)

4.40 (3.19)

4.07 (3.51)

Sham

7.59 (4.13)

4.98 (3.72)

4.51 (4.04)

Depression

Total

3.04 (2.62)

4.13 (3.17)

4.55 (3.51)

CES

3.03 (2.48)

4.24 (3.22)

4.47 (3.36)

Sham

3.06 (2.78)

4.02 (3.14)

4.63 (3.67)

Fatigue

Total

2.29 (2.81)

3.14 (2.30)

3.33 (2.50)

CES

1.95 (2.71)

3.15 (2.21)

3.34 (2.47)

Sham

2.63 (2.89)

3.14 (2.39)

3.32 (2.55)

Pain

Total

1.35 (2.01)

1.17 (1.50)

1.23 (1.72)

CES

1.24 (2.05)

1.25 (1.44)

1.14 (1.65)

Sham

1.45 (1.98)

1.09 (1.56)

1.32 (1.80)

Sleep

Total

40.50 (24.28)

40.55 (20.08)

39.70 (20.66)

CES

40.70 (24.83)

38.70 (18.28)

38.50 (20.19)

Sham

40.30 (23.87)

42.44 (21.73)

40.91 (21.21)